Navigation Links
Why were the HIV prevention trials in commercial sex workers abandoned?

One promising approach to help stem the global HIV epidemic is to give commercial sex workers an HIV medication (such as the drug tenofovir) before they have high risk sex in the hope of reducing their chances of becoming infected, an approach called "pre-exposure prophylaxis" (PREP). But activist groups, including Act Up-Paris have "halted the progress of at least two important clinical trials of tenofovir as PREP and brought negative attention to tenofovir, somewhat similar to that visited on thalidomide more than four decades ago," say two researchers in an essay in the open access global health journal PLoS Medicine.

The dramatic protest at the XV International AIDS Conference in Bangkok, Thailand last year against a PREP trial of tenofovir among Cambodian commercial sex workers caught the world's media attention. But Jerome Singh, of the Centre for the AIDS Programme of Research in South Africa, University of KwaZulu–Natal, and Edward Mills of the Department of Clinical Epidemiology and Biostatistics, McMaster University, Canada, argue that "if tenofovir is someday proven to be clinically efficacious as a PREP, today's irresponsible reporting and activism surrounding tenofovir could cause those in need to snub the drug if, or when, it becomes licensed for use as a PREP."

In a commentary on the essay, Joep Lange, who was the President of the International AIDS Society at the time of the Bangkok conference, criticizes the protestors who derailed the PREP trials.

In the absence of an effective HIV vaccine, which is felt to be the only tool that can definitively break the epidemic, Lange says that there is a pressing need to develop female-controlled prevention technologies that do not require the male partner's consent, and the protestors are getting in the way of such development. "Activist groups have now managed to derail several PREP trials, arguably the most important studies for those at high risk of acquiring HIV infection around the
'"/>

Source:PLoS


Page: 1 2

Related biology news :

1. President Bushs cut to AIDS prevention in Africa would be devastating
2. WCS says avian flu prevention should focus on farms, markets
3. Vaginal gel may provide a new approach to HIV prevention
4. Successful cell engineering may lead to mad cow prevention, say researchers
5. U of M study examines kidney stone prevention in astronauts
6. Tamoxifen for breast cancer prevention does not benefit most women
7. Study defines effective microbicide design for HIV/AIDS prevention
8. Plant-derived molecules, genetic manipulation point to future chemoprevention methods
9. Investment level in HIV prevention programs related to HIV incidence in the United States
10. No magic tomato? Study breaks link between lycopene and prostate cancer prevention
11. Use of PET can reduce, may eliminate more strenuous drug development trials with animals

Post Your Comments:
(Date:12/1/2009)...s have two different feeding strategies. A large ...ng that they are generalist predators feeding on o... Some, however, are "herbivorous". This is not t...of their diets consist of plant-derived matter. Fo...y plants to attract ants, called extra-floral nect...
(Date:12/1/2009)...iNose is pleased to announce the publication of re...ng the efficacy and tolerability of its novel, int...ent of chronic rhinosinusitis with nasal polyps in...ional and European Rhinologic Societies. , Chro...disease that can significantly reduce a patient,s ...
(Date:12/1/2009)...imer,s disease, nerve cell degeneration plays a cr... may possibly be derived from steering the generat...e been published in the current issue of the renow...w years ago, neurogenesis the process of nerve ce... the adult brain. The textbooks asserted that dead...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2New source discovered for the generation of nerve cells in the brain 2Intensive Dialysis Doesnt Save Lives of the Sickest 59940 1Intensive Dialysis Doesnt Save Lives of the Sickest 59940 2Intensive Dialysis Doesnt Save Lives of the Sickest 59940 3Sex of Twins May Affect Outcomes 59938 1Sex of Twins May Affect Outcomes 59938 2Sex of Twins May Affect Outcomes 59938 3Pitt NIH team find way to protect healthy cells from radiation damage 59936 1Pitt NIH team find way to protect healthy cells from radiation damage 59936 2
...ve shown for the first time that carbon nanotubes ...ue. The new technique could change the way doctors...t a solution of nanotubes into a fracture to promo...sue of the American Chemical Society,s journal Che...ientific society. , The success of a bone graft d...
...it felt the last time you burned your finger on a ...ning pain in your hands or feet all the time and k... , David Fink, M.D.It,s called neuropathic pain, ...d medical conditions, especially diabetes. Drugs h...aused by damage to sensory neurons that transmit p...
... California, San Diego biochemists have developed ...ing mystery: how the same proteins can play differ...ncluding those leading to immune responses and can...re published in the September 16 issue of the jour... a computational approach could represent the intr...
Other Biology News:Nanotubes inspire new technique for healing broken bones 2Nanotubes inspire new technique for healing broken bones 3Scientists use gene transfer technology and common virus to block neuropathic pain in animals 2Scientists use gene transfer technology and common virus to block neuropathic pain in animals 3Scientists use gene transfer technology and common virus to block neuropathic pain in animals 4Scientists use gene transfer technology and common virus to block neuropathic pain in animals 5Computer modeling reveals hidden conversations within cells 2Computer modeling reveals hidden conversations within cells 3
(Date:12/2/2009)...Newswire/ -- TechConnect World, an event bringing ... product integration in cleantech, nanotech, biote...for technology abstracts and business presentation...in association with the Nano Science and Technolog...ustainable Industries Organization (CTSI), will br...
(Date:12/2/2009)...e/ -- S*BIO Pte Ltd today announced data presentat...The American Society of Hematology 51st Annual Mee...l be presented on the clinical results from the Ph...s safety, tolerability and pharmacokinetic/pharmac...om 100 to 600 mg. These doses were administered on...
(Date:12/2/2009)...ewswire-Asia/ -- Simcere Pharmaceutical Group,("Si... pharmaceutical company,specializing in the develo...eric and proprietary pharmaceuticals in China, tod...ded in China,s National Drug Reimbursement List,("...man Resources and Social,Security on November 30, ...
(Date:12/2/2009)...e-Asia/ -- The world is going through,extraordinar... part of many,businesses and industries. It turns ...mmune to the economic downturn, because illness do... of the difficult times this year, the pharmaceuti...mp;D center in Shanghai, the largest of,its kind i...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...ept. 5 /PRNewswire/ - GenoLogics, a leading develo...for life sciences research,announced today the Com...(TM) Applications Program, and its Geneus product ...he Affymetrix, Inc. (Nasdaq:,AFFX) GeneChip(R) mic...ated,its Geneus solution, built for multiple genom...
...ll review common U.S. laws on research and process...nce solutions, ST. LOUIS, Sept. 5 Sigma-Aldrich ...gazine, will present a Web,conference on laborator...1,p.m. EST. The online conference will review comm...d process laboratories and provide attendees,with ...
...., Sept. 5 A study in the August 2007,issue of Pe...,1,5-anhydroglucitol (1,5-AG) blood test to evalua...o target postprandial hyperglycemia (elevated,afte...cose levels is,important in achieving optimal glyc...ular complications, the leading cause of death in ...
Other Biology Technology:GenoLogics' Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform 2GenoLogics' Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform 3Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 2Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 3Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes 2
Recorder REC-111 single-channel from GE Healthcare, formerly Amersham Biosciences
...or when you need to make your strain of cells comp...cy. Our services for preparing competent cells are...tions. MCLab's custom competent cell service offer...Fast turnaround Quality control performance test...
MEK1, total EIA Kit from Assay Designs/Stressgen Bioreagents
Argon Calibration Source from Ocean Optics
Biology Products: